Gamunex c infusion

The GAMUNEX-C infusion line can be flushed with 5% dextrose in water (D5/W) or 0.9% sodium chloride for injection. If dilution is required, GAMUNEX-C may be diluted with 5% dextrose in water (D5/W). Do not dilute with saline. Content of vials may be pooled under aseptic conditions into sterile infusion bags and infused within 8 hours after pooling.

drugs, administer. GAMUNEX-C at the minimum infusion rate hyponatremia from a pseudohyponatremia that is associated with concomitant decreased.

In clinical studies of Gamunex-C, the most common adverse reactions associated with subcutaneous administration were infusion site reactions

infusion rate for all sites combined is 240 mL/hr. Gamunex-C SC. Prime tubing with Gamunex-C solution. SC infusion rate. Adults: 20 mL/hr per infusion site; up

drugs, administer. GAMUNEX-C at the minimum infusion rate hyponatremia from a pseudohyponatremia that is associated with concomitant decreased.

GAMUNEX-C vial size. Gauge of needle to immunodeficiency stabilized on GAMUNEX intravenous infusion at a mean dose of 417 mg/kg, range.

In case of hypersensitivity, discontinue GAMUNEX-C infusion immediately and institute appropriate treatment. Monitor renal function

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) † (Ф for Gamunex-C) are recommended to reduce the risk of infusion related reactions.

infusion rate practicable. Ensure adequate Gamunex-C, Gammaked, and Gammagard may be administered intravenously or subcutaneously.